250 related articles for article (PubMed ID: 7571853)
1. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
Matsumoto K
Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
Oishi K; Sonoda F; Kobayashi S; Iwagaki A; Nagatake T; Matsushima K; Matsumoto K
Infect Immun; 1994 Oct; 62(10):4145-52. PubMed ID: 7927669
[TBL] [Abstract][Full Text] [Related]
3. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.
Fujii T; Kadota J; Kawakami K; Iida K; Shirai R; Kaseda M; Kawamoto S; Kohno S
Thorax; 1995 Dec; 50(12):1246-52. PubMed ID: 8553295
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil response to Pseudomonas aeruginosa in respiratory infection.
Ahmed K; Dai TC; Ichinose A; Masaki H; Nagatake T; Matsumoto K
Microbiol Immunol; 1993; 37(7):523-9. PubMed ID: 7694053
[TBL] [Abstract][Full Text] [Related]
5. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1995 Jul; 108(1):116-22. PubMed ID: 7606944
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis.
Koga T
Kurume Med J; 1993; 40(3):139-46. PubMed ID: 8139213
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
9. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog.
Ozaki T; Maeda M; Hayashi H; Nakamura Y; Moriguchi H; Kamei T; Yasuoka S; Ogura T
Am Rev Respir Dis; 1989 Dec; 140(6):1595-601. PubMed ID: 2513762
[TBL] [Abstract][Full Text] [Related]
10. Effects of the beige mutation on respiratory tract infection with Pseudomonas aeruginosa in mice.
Tanaka E; Yuba Y; Sato A; Kuze F
Exp Lung Res; 1994; 20(4):351-66. PubMed ID: 7988496
[TBL] [Abstract][Full Text] [Related]
11. Diffuse panbronchiolitis--pathophysiology and treatment mechanisms.
Yanagihara K; Kadoto J; Kohno S
Int J Antimicrob Agents; 2001; 18 Suppl 1():S83-7. PubMed ID: 11574201
[TBL] [Abstract][Full Text] [Related]
12. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide].
Maeda M; Ozaki T; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674
[TBL] [Abstract][Full Text] [Related]
13. Chronic
Matsumoto T; Fujita M; Hirano R; Uchino J; Tajiri Y; Fukuyama S; Morimoto Y; Watanabe K
Int J Chron Obstruct Pulmon Dis; 2016; 11():2321-2327. PubMed ID: 27703342
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.
Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K
Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803
[TBL] [Abstract][Full Text] [Related]
15. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G
PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection.
Nakamura H; Fujishima S; Inoue T; Ohkubo Y; Soejima K; Waki Y; Mori M; Urano T; Sakamaki F; Tasaka S; Ishizaka A; Kanazawa M; Yamaguchi K
Eur Respir J; 1999 Jun; 13(6):1371-9. PubMed ID: 10445614
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.
Kasetty G; Papareddy P; Bhongir RK; Egesten A
J Pharmacol Exp Ther; 2016 Apr; 357(1):66-72. PubMed ID: 26865680
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1994 Oct; 106(4):1116-23. PubMed ID: 7924482
[TBL] [Abstract][Full Text] [Related]
19. [Effect of erythromycin on neutrophil function in chronic respiratory tract diseases with Pseudomonas infection].
Kadota J; Oda H; Sakito O; Sawa H; Morikawa N; Mukae H; Senju R; Tomono K; Fukushima K; Hiratani K
Kansenshogaku Zasshi; 1991 Mar; 65(3):277-85. PubMed ID: 1649231
[TBL] [Abstract][Full Text] [Related]
20. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
